13232
clinical study

AI in Routine Use: Results of a Large-Scale Test Across Germany and Austria

Materials & Methods

A study of over 3,000 native cranial CT scans from 140 hospitals in Germany and Austria (March to April 2022) analyzed 2,707 scans using AI for hemorrhage detection. Results were compared with interpretations from over 70 teleradiologists who were unaware of the suspected AI findings. Discrepancies were reviewed by two experienced neuroradiologists using prior controls or findings.

Results

Of the 2,707 cranial CT scans analyzed, 189 cases (7%) showed intracranial hemorrhage (ICH) identified by both AI and radiologists. AI flagged 30 additional cases not initially described by radiologists. On re-evaluation, 10 were confirmed as true positives, eight were questionable, and 12 were false positives. Overall, AI helped detect 199 ICHs, with over 5% initially missed by radiologists alone.

Conclusions

AI can enhance radiological reporting, particularly in teleradiology, through enhanced detection as demonstrated by practical application and previous studies.

Disclaimer: This links to a third-party website, which may require credentials to review. 

Explore the Latest AI Insights, Trends and Research

Deepak Srikant

<p>Deepak Srikant is a global marketing executive with over 20 years of experience, specializing in the commercialization of medical devices and digital health solutions. He has a proven track record in driving growth, having led successful go-to-market strategies, product launches and market expansions across the U.S. and EMEA.</p> <p>Srikant’s expertise extends to upstream and downstream marketing, professional education and sales enablement. His leadership at companies such as Silk Road Medical (acquired by Boston Scientific) and Aptus Endosystems (acquired by Medtronic) has consistently resulted in revenue growth, enhanced customer retention and successful product adoption.</p> <p>Srikant holds an MBA from the Yale School of Management and a bachelor’s degree in mechanical engineering from Rensselaer Polytechnic Institute. Currently, he leads product marketing for Aidoc’s cardiovascular service line.</p>

Laci Costa

<p>Laci Costa is the Director of Neurovascular Product Marketing at Aidoc. She leads marketing and commercial strategy for the neuro AI portfolio of products. She has 16 years of experience working in the medical device and healthcare industry, with over 12 years dedicated to neurovascular solutions.</p> <p>Costa’s known for her expertise in the neurovascular industry, go-to-market experience with new technologies and upstream and downstream product marketing leadership. She’s held various leadership positions in product marketing, clinical education and professional affairs spanning across start-up organizations to large publicly traded companies.</p> <p>Costa holds a bachelor’s degree in psychology from the University of Oklahoma and an MBA from USC Marshall School of Business.</p>

Ayden Jacob, MD, MSc

<p>Ayden Jacob, MD, MSc, is a physician-engineer with expertise in AI, data science and healthcare economics. He’s passionate about leveraging AI and data science to solve complex healthcare issues through the specific prism of economics and finance. At Aidoc, Dr. Jacob’s work focuses on quantifying the clinical and financial impact of innovative AI solutions deployed throughout the healthcare ecosystem.</p> <p>Dr. Jacob’s diverse expertise reflects a commitment to advancing healthcare through data-driven solutions that enhance both patient outcomes and operational effectiveness. A graduate of Yeshiva University and the University of Oxford, Dr. Jacob employs an interdisciplinary approach to innovating at the intersection of clinical medicine, engineering and informatics.</p>